Name Meldonium-MIK caps. The main active ingredient Meldonium Release form Capsules Dosage 250 mg. Indications for use As part of combination therapy in the following cases: cardiovascular diseases – stable angina pectoris, chronic heart failure (NYHA I-III functional class), cardiomyopathy, functional disorders of the cardiovascular system; acute and chronic ischemic disorders of cerebral circulation; reduced performance, physical and psycho-emotional overload; the recovery period after cerebrovascular accidents, head injuries and encephalitis. Method of administration and doses For oral administration. Due to the possible tonic effect, it is recommended to use the drug in the morning. Adults are prescribed 0.5- (2-4 capsules of 250 mg or 1-2 capsules of 500 mg) per day, using the entire dose at once or dividing it into 2 times. The maximum daily dose is . The duration of the course of treatment is 4-6 weeks. Treatment courses can be repeated 2-3 times a year. Use during pregnancy and lactation The safety of the drug during pregnancy has not been proven. To avoid possible adverse effects on the fetus, it is not prescribed during pregnancy. In connection with the release of meldonium into mother’s milk, in cases where the drug is used during lactation, breastfeeding should be discontinued. Precautions For patients with insufficiency of the liver and / or kidneys, it is necessary to reduce the dose of meldonium. Elderly patients with insufficiency of liver and / or kidney activity should reduce the dose of meldonium. Meldonium is not used in children under the age of 18 due to the lack of data on safety and efficacy. Many years of experience in the treatment of acute myocardial infarction and unstable angina in cardiology departments shows that meldonium is not a first-line drug in acute coronary syndrome. Interaction with other drugs The drug Meldonium-MIC can be used (together with nitrates of prolonged action and other antianginal agents, cardiac glycosides and diuretic drugs. It can also be combined with anticoagulants, antiplatelet agents, antiarrhythmic drugs and other drugs that improve microcirculation. It should be borne in mind that Meldonium- MICs may enhance the effect of drugs containing glyceryl trinitrates, nifedipine, beta-blockers, other antihypertensive drugs and peripheral vasodilators.Do not use together with other drugs containing meldonium, as the risk of side effects may increase. another component of the drug; increased intracranial pressure (in case of impaired venous outflow, intracranial tumors); liver or kidney failure (there are no sufficient data on the safety of use); od pregnancy and lactation; children under 18 years of age (safety not tested). One capsule contains: active ingredient: meldonium – 250 mg or 500 mg. Excipients: magnesium stearate, potato starch, colloidal silicon dioxide. The composition of the capsule shell: gelatin, glycerin, purified water, titanium dioxide, sodium lauryl sulfate. Overdose No cases of overdose have been reported. The drug is low toxic and does not cause severe side effects. Symptoms: in case of low blood pressure, headaches, dizziness, tachycardia, general weakness are possible. Treatment: symptomatic. In case of severe overdose, it is necessary to monitor the functions of the liver and kidneys. Hemodialysis is not essential in case of an overdose of meldonium due to its pronounced protein binding. Side effects The drug is usually well tolerated. However, in sensitive patients, as well as in cases of overdose, side effects are possible. The following side effects are classified according to organ system groups and frequency of occurrence of MedDRA: very often (>1/10), often (>1/100, <1/10), infrequently (>1/1000, <1/100), rarely (>1/10,000 to <1/1000), very rare (<1/10,000), not known (cannot be determined from available data). Blood and lymphatic system disorders Not known: eosinophilia. Immune system disorders Common: allergic reactions. Cardiac disorders: In some cases: tachycardia. Disorders of the circulatory system In some cases: low blood pressure. Gastrointestinal disorders Common: dyspepsia. Nervous system disorders Common: headaches. Not known: arousal. Respiratory, chest and mediastinal disorders Not known: dyspnea. General disorders Not known: general weakness. Storage conditions Store in a place protected from moisture and light at temperatures from to . Store in a place inaccessible to children. Buy Meldonium-MIC capsules 250mg No. 10x3 Price for Meldonium-MIC capsules 250mg No. 10x3
INN | Meldonium |
---|---|
The code | 48 662 |
Barcode | 4 810 046 003 523 |
Dosage | 250mg |
Active substance | Meldonium |
Manufacturer | Minskintercaps UP, Belarus |
Reviews
There are no reviews yet.